Translational

From left: CNIO researchers Manuel Valiente and Pedro García-Gómez at the Spanish National Cancer Research Centre (CNIO). /MadMoviex.CNIO

Translational
29.09.2026 Cancer Cell. New therapeutic strategy could open the door to preventing brain metastasis Metastasis, the process by which a tumour spreads throughout the body, is associated with the...

CNIO researchers Bárbara Hernando and Geoff Macintyre. /Laura Lombardía. CNIO

Translational
10.09.2026 Nature. Scientists reveal what damages the DNA in most prostate cancers Cancer begins with errors in the DNA inside our cells, and those errors are often more complicated...

Translational
08.09.2026 Molecular Cell. Uncovering how a key RNA works sheds light on one of the major challenges in modern biology For years, proteins have taken centre stage in biology because they are the main executors of...

Part of CNIO Breast Cancer Unit. From left: Manuel Muñoz, María José Bueno, Miguel Quintela, Verónica Jiménez and Leonardo Garma. / MadMoviex. CNIO

Translational
03.09.2026 The Journal of Clinical Investigation. New way to improve the effectiveness of antiangiogenic drugs and immunotherapy in breast cancer CNIO’s Breast Cancer Clinical Research Unit has identified a new cancer-related target in mice:...

Nicola D’Amelio (right), Fundación Occident Visiting Professor, with Jorge Martínez Torrecuadrada, head of the CNIO Protein Production Unit. /MadMoviex. CNIO

Translational
13.08.2026 What if cancer treatment came with a yogurt? Chemist Nicola D’Amelio is developing a new idea at the Spanish National Cancer Research Centre...

MamoRisk team at the Spanish National Cancer Research Centre (CNIO). From left: Cindy Katherin Huertas, Guillermo Pita, Anna González Neira and Sara Sánchez. / MadMoviex. CNIO

Translational
20.07.2026 MamoRisk. MamoRisk project to validate in Spain a new breast cancer risk prediction model The mammograms currently offered by Spain’s National Health System to women according to their age...

CNIO researchers Rafael Fernández Leiro and Marisol Soengas. /Laura M. Lombardía. CNIO

Translational
02.07.2026 CNIO to seek drugs to extend the effectiveness of immunotherapy to more tumors, using a strategy selected by the European Research Council Immunotherapy has significantly improved the treatment of aggressive tumors such as melanoma, but in...

Desde la izda.: Fernando Peláez, Raúl Rabadán, Carl June, Michel Sadelain, Manel Juan, Antonio Pérez-Mártínez y Luis Álvarez-Vallina, en la entrega de los Premios Fundación BBVA Fronteras del Conocimiento, en Bilbao. / CNIO

Translational
25.06.2026 June and Sadelain, the pioneers of CAR-T cell immunotherapy, receive the Frontiers of Knowledge Award Carl June and Michel Sadelain, the pioneers of cell-based immunotherapies, are the winners of the...

Translational
15.06.2026 Álvarez-Vallina aims to generate STAb-T cells against multiple myeloma directly in the body Multiple myeloma is the second most common blood cancer in adults. One of the major advances in its...